ALPMY 股價走勢圖
ALPMY 收益
Astellas Pharma Inc
$14.7
-1.63%
$-0.24
收盤價：Aug 28, 16:00:00 GMT-4
$14.7
0%
$0
盤後：Aug 28, 16:51:58 GMT-4
返回
Astellas Pharma Inc (ALPMY) 收益
關鍵數據
前收市價
$14.95
開盤價
$14.74
當日範圍
$14.68 - $14.9
52週區間
$10.03 - $17.35
交易量
3.3K
平均成交量
204.0K
股息收益率
--
每股盈餘 (TTM)
1.00
市值
$26.6B
什麼是 Astellas Pharma, Inc.？
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To. The firm mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
